These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36707393)

  • 1. ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease.
    Jena A; Grover N; Bhatia P; Singh M; Lad D; Prasad KK; Singh H; Dutta U; Sharma V
    Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):25-30. PubMed ID: 36707393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
    Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
    BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease.
    Suzuki S; Uchiyama K; Motoi Y; Yoshii Y; Inoue Y; Kubota T; Odahara S; Ohtaki Y; Takami S; Ito Z; Sato N; Ohkusa T; Koido S; Saruta M
    BMC Gastroenterol; 2023 Jul; 23(1):239. PubMed ID: 37454061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
    Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
    Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Chao K; Wang X; Cao Q; Qian J; Wu K; Zhu X; Yang H; Liang J; Lin L; Huang Z; Zhang Y; Huang Y; Sun Y; Xue X; Huang M; Hu P; Lan P; Gao X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1592-1599. PubMed ID: 28570428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of
    Kojima Y; Hirotsu Y; Omata W; Sugimori M; Takaoka S; Ashizawa H; Nakagomi K; Yoshimura D; Hosoda K; Suzuki Y; Mochizuki H; Omata M
    World J Gastroenterol; 2018 Jan; 24(4):511-518. PubMed ID: 29398872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
    Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B
    Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
    Kakuta Y; Kinouchi Y; Shimosegawa T
    J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
    Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
    PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease.
    Zhu X; Wang XD; Chao K; Zhi M; Zheng H; Ruan HL; Xin S; Ding N; Hu PJ; Huang M; Gao X
    Aliment Pharmacol Ther; 2016 Nov; 44(9):967-975. PubMed ID: 27604507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
    Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients.
    Shah SA; Paradkar M; Desai D; Ashavaid TF
    J Gastroenterol Hepatol; 2017 Mar; 32(3):620-624. PubMed ID: 27416873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs.
    Skrzypczak-Zielinska M; Borun P; Bartkowiak-Kaczmarek A; Zakerska-Banaszak O; Walczak M; Dobrowolska A; Kurzawski M; Waszak M; Lipinski D; Plawski A; Slomski R
    Mol Diagn Ther; 2016 Oct; 20(5):493-9. PubMed ID: 27307154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review.
    Desai D; Jena A; Sharma V; Hibi T
    Expert Rev Clin Pharmacol; 2023; 16(7):643-653. PubMed ID: 37387532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs.
    Jung YS; Cheon JH; Park JJ; Moon CM; Kim ES; Lee JH; Kim SW; Kim JH; Hong SP; Kim TI; Kim WH
    J Hum Genet; 2010 Feb; 55(2):121-3. PubMed ID: 19960028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.